These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 27234555)

  • 21. Immune responses of swine inoculated with a recombinant fowlpox virus co-expressing P12A and 3C of FMDV and swine IL-18.
    Ma M; Jin N; Shen G; Zhu G; Liu HJ; Zheng M; Lu H; Huo X; Jin M; Yin G; Ma H; Li X; Ji Y; Jin K
    Vet Immunol Immunopathol; 2008 Jan; 121(1-2):1-7. PubMed ID: 17706296
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Increased humoral antibody response of foot-and-mouth disease virus vaccine in growing pigs pre-treated with poly-γ-glutamic acid.
    Lee JH; Kang IJ; Kim AR; Noh YS; Chung HC; Park BK
    J Vet Sci; 2016 Jun; 17(2):253-6. PubMed ID: 26645341
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunogenicity and T cell recognition in swine of foot-and-mouth disease virus polymerase 3D.
    García-Briones MM; Blanco E; Chiva C; Andreu D; Ley V; Sobrino F
    Virology; 2004 May; 322(2):264-75. PubMed ID: 15110524
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Construction and identification of a recombinant PRRSV expressing protective antigens of type O foot-and-mouth disease virus].
    Tong W; Xu Y; Zhou Y; Jiang Y; Zhang S; Wang Y; Zhu J; Yu L; Sun J; Chen H; Tong G
    Sheng Wu Gong Cheng Xue Bao; 2012 Dec; 28(12):1431-40. PubMed ID: 23593867
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Protection of guinea pigs and swine by a recombinant adenovirus expressing O serotype of foot-and-mouth disease virus whole capsid and 3C protease.
    Lu Z; Bao H; Cao Y; Sun P; Guo J; Li P; Bai X; Chen Y; Xie B; Li D; Liu Z; Xie Q
    Vaccine; 2008 Dec; 26 Suppl 6():G48-53. PubMed ID: 19178894
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genome analysis and development of infectious cDNA clone of a virulence-attenuated strain of foot-and-mouth disease virus type Asia 1 from China.
    Xin A; Li H; Li L; Liao D; Yang Y; Zhang N; Chen B
    Vet Microbiol; 2009 Sep; 138(3-4):273-80. PubMed ID: 19410387
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Early pathogenesis of the foot-and-mouth disease virus O/JPN/2010 in experimentally infected pigs.
    Yamada M; Fukai K; Morioka K; Nishi T; Yamazoe R; Kitano R; Shimada N; Yoshida K; Kanno T; Sakamoto K; Yamakawa M
    J Vet Med Sci; 2018 Apr; 80(4):689-700. PubMed ID: 29515043
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mutational analysis of foot and mouth disease virus nonstructural polyprotein 3AB-coding region to design a negative marker virus.
    Bhatt M; Mohapatra JK; Pandey LK; Mohanty NN; Das B; Prusty BR; Pattnaik B
    Virus Res; 2018 Jan; 243():36-43. PubMed ID: 29037477
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Marker vaccine potential of a foot-and-mouth disease virus with a partial VP1 G-H loop deletion.
    Fowler VL; Knowles NJ; Paton DJ; Barnett PV
    Vaccine; 2010 Apr; 28(19):3428-34. PubMed ID: 20199761
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dose-dependent responses of pigs infected with foot-and-mouth disease virus O/JPN/2010 by the intranasal and intraoral routes.
    Fukai K; Yamada M; Morioka K; Ohashi S; Yoshida K; Kitano R; Yamazoe R; Kanno T
    Arch Virol; 2015 Jan; 160(1):129-39. PubMed ID: 25281431
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sequences outside that of residues 93-102 of 3A protein can contribute to the ability of foot-and-mouth disease virus (FMDV) to replicate in bovine-derived cells.
    Ma X; Li P; Bai X; Sun P; Bao H; Lu Z; Cao Y; Li D; Chen Y; Qiao Z; Liu Z
    Virus Res; 2014 Oct; 191():161-71. PubMed ID: 25116389
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combined administration of synthetic RNA and a conventional vaccine improves immune responses and protection against foot-and-mouth disease virus in swine.
    Borrego B; Blanco E; Rodríguez Pulido M; Mateos F; Lorenzo G; Cardillo S; Smitsaart E; Sobrino F; Sáiz M
    Antiviral Res; 2017 Jun; 142():30-36. PubMed ID: 28315707
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Detection of genome, antigen, and antibodies in oral fluids from pigs infected with foot-and-mouth disease virus.
    Senthilkumaran C; Yang M; Bittner H; Ambagala A; Lung O; Zimmerman J; Giménez-Lirola LG; Nfon C
    Can J Vet Res; 2017 Apr; 81(2):82-90. PubMed ID: 28408775
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Enhancement of DNA vaccine (P12A3C-pcDNA) efficacy against foot-and-mouth disease by coadministration of interleukin-18-expressing (IL18 pcDNA) plasmid in guinea-pigs.
    Siva Reddy K; Muralidhar Rao D; Badrinaryana N; Suryanaryana VV; Reddy GR
    FEMS Immunol Med Microbiol; 2010 Dec; 60(3):261-9. PubMed ID: 21039923
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Generation of an infectious cDNA clone of an FMDV strain isolated from swine.
    Liu G; Liu Z; Xie Q; Chen Y; Bao H; Chang H; Liu X
    Virus Res; 2004 Sep; 104(2):157-64. PubMed ID: 15246653
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Construction and characterization of 3A-epitope-tagged foot-and-mouth disease virus.
    Ma X; Li P; Sun P; Bai X; Bao H; Lu Z; Fu Y; Cao Y; Li D; Chen Y; Qiao Z; Liu Z
    Infect Genet Evol; 2015 Apr; 31():17-24. PubMed ID: 25584768
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Preserved immunogenicity of an inactivated vaccine based on foot-and-mouth disease virus particles with improved stability.
    Caridi F; Vázquez-Calvo Á; Borrego B; McCullough K; Summerfield A; Sobrino F; Martín-Acebes MA
    Vet Microbiol; 2017 May; 203():275-279. PubMed ID: 28619156
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neutralizing antibody responses to foot-and-mouth disease quadrivalent (type O, A, C and Asia 1) vaccines in growing calves with pre-existing maternal antibodies.
    Patil PK; Sajjanar CM; Natarajan C; Bayry J
    Vet Microbiol; 2014 Mar; 169(3-4):233-5. PubMed ID: 24508311
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunogenicity of T7 bacteriophage nanoparticles displaying G-H loop of foot-and-mouth disease virus (FMDV).
    Xu H; Bao X; Lu Y; Liu Y; Deng B; Wang Y; Xu Y; Hou J
    Vet Microbiol; 2017 Jun; 205():46-52. PubMed ID: 28622860
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Poly(I:C) combined with multi-epitope protein vaccine completely protects against virulent foot-and-mouth disease virus challenge in pigs.
    Cao Y; Lu Z; Li Y; Sun P; Li D; Li P; Bai X; Fu Y; Bao H; Zhou C; Xie B; Chen Y; Liu Z
    Antiviral Res; 2013 Feb; 97(2):145-53. PubMed ID: 23219974
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.